. Substance P and capsaicin release prostaglandin E 2 from rat intrapulmonary bronchi. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L1006-L1012, 1998.-We hypothesized that substance P and capsaicin would cause the release of prostaglandin E 2 (PGE 2 ) from intrapulmonary bronchi isolated from Sprague-Dawley rats. Substance P (1 µM) caused the release of PGE 2 , measured with enzyme immunoassay, from the isolated airway segments; PGE 2 release was inhibited by the neurokinin (NK) 1 -receptor antagonist, RP-67580, by inhibition of cyclooxygenase with meclofenamate, and by removal of the epithelium. The release of PGE 2 caused by capsaicin (1 µM) was similar in magnitude to that caused by substance P. The capsaicin-induced release of PGE 2 was inhibited by desensitization of sensory nerves with capsaicin and by RP-67580, meclofenamate, and epithelial denudation. We conclude that activation of NK 1 receptors on epithelium causes release of PGE 2 , which most likely represents the ultimate mediator of airway smooth muscle relaxation, produced by exogenous neuropeptides and by activation of the sensory nerve inhibitory system. Epithelial damage, such as that seen in asthmatic airways, would disrupt this protective system in the lungs, which could contribute to the development of airway disease. neurokinin type 1 receptors; epithelium; C fibers IT IS WIDELY HELD THAT neuropeptides released from C fibers are involved in mediating proinflammatory effects that have relevance to the pathogenesis of human airway disease such as asthma. Recently, however, several studies have shown that these same mediators exert inhibitory or protective effects in the lungs. Specifically, airway relaxation has been shown in rats and mice. In perhaps the first demonstration of relaxation responses to tachykinins, Frossard and Muller (11) showed that substance P relaxed isolated rat tracheal segments and that the relaxation responses were dependent on an intact epithelium. Using isolated mouse extrapulmonary bronchi, Manzini (23) not only corroborated their results but also demonstrated that endogenously released sensory neuropeptides also relax airway smooth muscle. In his study, Manzini showed that electrical field stimulation and capsaicin evoked relaxation responses in the mouse bronchus that were blocked by inhibition of cyclooxygenase, which also blocked substance P-induced relaxation responses. Although Manzini did not examine the effects of epithelium removal, a role for epithelial cells was inferred on the basis of these results and those of other studies (6, 11).
IT IS WIDELY HELD THAT neuropeptides released from C fibers are involved in mediating proinflammatory effects that have relevance to the pathogenesis of human airway disease such as asthma. Recently, however, several studies have shown that these same mediators exert inhibitory or protective effects in the lungs. Specifically, airway relaxation has been shown in rats and mice. In perhaps the first demonstration of relaxation responses to tachykinins, Frossard and Muller (11) showed that substance P relaxed isolated rat tracheal segments and that the relaxation responses were dependent on an intact epithelium. Using isolated mouse extrapulmonary bronchi, Manzini (23) not only corroborated their results but also demonstrated that endogenously released sensory neuropeptides also relax airway smooth muscle. In his study, Manzini showed that electrical field stimulation and capsaicin evoked relaxation responses in the mouse bronchus that were blocked by inhibition of cyclooxygenase, which also blocked substance P-induced relaxation responses. Although Manzini did not examine the effects of epithelium removal, a role for epithelial cells was inferred on the basis of these results and those of other studies (6, 11) .
Recently, Szarek et al. (35) confirmed and extended the results of both of these studies. In that study, our laboratory found that substance P and neurokinin (NK) A relaxed airway segments isolated from SpragueDawley rats. The relaxation responses caused by the tachykinins were dependent on the epithelium and were blocked by inhibition of cyclooxygenase and by NK 1 -receptor antagonism. We also showed that endogenous tachykinins released in response to capsaicin and electrical field stimulation relaxed isolated airway segments. The fact that these responses were dependent on sensory nerves was confirmed in experiments in which airway segments that had been desensitized by capsaicin no longer relaxed in response to a second challenge with capsaicin or to electrical field stimulation. The C fiber-dependent responses were antagonized by inhibition of cyclooxygenase, epithelial denudation, and NK 1 -receptor antagonism. These responses were not an artifact of in vitro methods because, in intact anesthetized ventilated rats, substance P and capsaicin, administered by intravenous injection, evoked bronchodilation as evidenced by the near-complete reversal of bronchoconstriction induced by an infusion of bethanechol (35) . On the basis of these results, we concluded that C-fiber activation releases sensory neuropeptide(s) that activate epithelial NK 1 receptors, causing release of an inhibitory prostaglandin (PG), the ultimate mediator of relaxation responses. We have termed this inhibitory pathway the sensory nerve inhibitory system. The results of these previous studies provide pharmacological evidence for a role of an inhibitory PG in mediating the response. A more definitive approach to confirm our proposed mechanism by which the sensory nerve inhibitory system relaxes airway smooth muscle would be to measure release of PGs from the airways in response to exogenous and endogenous sensory neuropeptides. Thus, on the basis of our previous study and those cited above, we hypothesized in this study that substance P and capsaicin would cause the release of PGE 2 from isolated airway segments. To test this hypothesis, we examined the effects of C-fiber desensitization, NK 1 -receptor antagonism, cyclooxygenase inhibition, and epithelium removal on release of the PG by substance P and by activation of the sensory nerve inhibitory system. In a previous study, Devillier and co-workers (6) showed that substance P caused the release of PGE 2 only from epithelium-intact tracheal segments of rats. However, in their study, they did not examine the effects of tachykinin-receptor antagonism or inhibition of cyclooxygenase on the substance Pinduced release of the prostanoid. Furthermore, the effects of endogenously released tachykinins on PGE 2 release have not been previously examined. The results of our study corroborate and extend the results of this earlier study and elucidate the mechanism whereby exogenous and endogenous sensory neuropeptides cause the release of PGE 2 .
METHODS
Preparation of airway segments. Male Sprague-Dawley rats (270-330 g) were anesthetized with an intraperitoneal injection of pentobarbital sodium (60 mg/kg) and exsanguinated, and the lungs and a portion of the trachea were removed and placed in aerated physiological salt solution [PSS; in mM: 117.9 NaCl, 4.7 KCl, 1.5 CaCl 2 ·2H 2 O, 1.2 KH 2 PO 4 , 1.1 MgCl 2 ·6H 2 O, 25 NaHCO 3 , and 5.6 glucose] at room temperature. Cylindrical segments of primary intrapulmonary bronchi comparable to those used in a previous study (35) by our laboratory were isolated from right caudal or left lobes with a dissecting microscope. In some segments, the epithelium was denuded by rotating the isolated segment on a roughened 18-gauge needle that had been inserted into the lumen. This procedure denudes the epithelium lining, which was confirmed histologically in a previous study (35) by our laboratory. Epithelium-intact and -denuded segments were cut open parallel to the lumen, and each segment was placed into a well of a 12-well tissue culture plate containing 1 ml of PSS.
Mediator release from airway segments. The airways were incubated for 1 h at 37°C in a metabolic shaker under an air-5% CO 2 atmosphere. The airway segments were washed with fresh medium after 30 min and at the end of the incubation. The washes were accomplished by carefully removing the medium and replacing it with 1 ml of fresh medium; this procedure was repeated three times in succession. To assess the effects of NK 1 -receptor blockade, cyclooxygenase inhibition, and C-fiber desensitization, we incubated epithelium-intact airways with RP-67580 (10 µM), meclofenamate (10 µM), or capsaicin (10 µM), respectively, during the last 30 min of the 1-h incubation period. After the last wash at the end of the 1-h incubation, RP-67580 and meclofenamate were added afresh; capsaicin was not added after the wash. We also examined the effects of inhibition of neutral endopeptidase on capsaicin-induced release of PGE 2 . In these experiments, phosphoramidon (10 µM) was added only after the last wash at the end of the 1-h incubation. Incubation of tissues with vehicles for inhibitors did not affect the release of PGE 2 in response to capsaicin or substance P.
After the last wash and the addition of inhibitors as appropriate, the airway segments were allowed to equilibrate briefly for an additional 15 min. In a previous study (35) by our laboratory, the airways were contracted with bethanechol to facilitate study of relaxation responses. Thus, to mimic the previous study as closely as possible, we added bethanechol (3 µM) after the 15-min incubation. Ten minutes after the bethanechol was added, 500 µl of buffer were removed; basal levels of PGE 2 were measured in this sample. In preliminary studies, we found that bethanechol did not affect the basal release of PGE 2 (P ϭ 0.956). Subsequently, vehicle, substance P (1 µM), or capsaicin (1 µM) was added to the remaining 500 µl, and the airways were incubated for an additional 6 min. The bronchi were then removed, and the buffer was collected and divided into aliquots. All samples were placed into microcentrifuge tubes that were then sealed and stored at Ϫ20°C until analyzed for PGE 2 levels by enzyme immunoassay (EIA). The airway segments were then blotted and weighed. With the use of an EIA kit for PGE 2 (Cayman Chemical, Ann Arbor, MI), the levels of PG were determined in the thawed samples according to the manufacturer's instructions.
Data representation and statistical analysis. The levels of PGE 2 measured by EIA were normalized to milligrams of airway tissue and divided by the appropriate incubation interval (10 or 6 min) to obtain a value for net mediator release (in pg · mg Ϫ1 · min Ϫ1 ). Release of PG is expressed as the ratio of stimulated to basal levels (S/B, where S equals PGE 2 release measured after challenge with substance P or capsaicin and B equals basal release of the PGE 2 measured in samples acquired just before addition of one of the stimuli) (36) .
A total of 67 animals was used in preliminary studies and in the studies described herein. In these experiments, four airway segments were isolated from each animal; one segment served as a control and the three remaining segments were treated as described. Comparison among the means of the treatment groups was accomplished with ANOVA. Because it was decided a priori which means would be compared after the experiment was completed, contrasts were defined between these means in the ANOVA (33) . In all analyses, P Յ 0.05 was considered significantly different. Statistical analyses were accomplished with Crunch Statistical Package, version 4 (Crunch Software, Oakland CA, 1991). Data are expressed as means Ϯ SE. The number of preparations (n) reported represent the number of animals from which airway segments were isolated.
Reagents. Most drugs and reagents were purchased from Sigma (St. Louis, MO). The NK 1 -selective receptor antagonist RP-67580 was kindly provided by Dr. C. Garret (Rhône-Poulenc Rorer, Vitry-sur-Seine cedex, France). Stock solutions for most of the drugs were prepared in water on the day of the experiment. Stock solutions of capsaicin were prepared in DMSO and diluted with PSS as appropriate. Substance P was dissolved in water, divided into aliquots, and stored frozen at Ϫ20°C. On the day of the experiment, an aliquot was removed from the freezer, allowed to thaw at room temperature, and diluted in PSS as appropriate. Stock solutions of the tachykinin-receptor antagonist were prepared in 50% polyethylene glycol 200 in saline. Control segments in each group were incubated with vehicle.
RESULTS

Release of PGE 2 from airway segments by substance P.
Basal release of PGE 2 was measured in the medium surrounding the airways just before the addition of substance P (Fig. 1) . Basal release of PGE 2 in meclofenamate-treated airways was significantly reduced relative to control segments (P ϭ 0.018). Incubation of airway segments with substance P (1 µM) increased the release of PGE 2 measured in the medium surrounding the airway segments as evidenced by the increase in the S/B (Fig. 1) . In a functional study, Szarek et al. (35) found that inhibition of cyclooxygenase, antagonizing NK 1 receptors, or removal of the epithelium blocked relaxation responses caused by substance P. Thus we examined the effects of these interventions on substance P-induced release of PGE 2 . Each of these interventions blocked the release of PGE 2 ( Fig. 1) .
Release of PGE 2 from airway segments by capsaicin. The same interventions as above (cyclooxygenase inhibition, NK 1 -receptor blockade, and epithelium removal) blocked capsaicin-induced relaxation responses in a functional study (35) . In addition, desensitization of C fibers by capsaicin blocked relaxation responses evoked by the sensory nerve inhibitory system (35) . Thus similar experiments were undertaken to examine the effects of these interventions on capsaicin-induced release of PGE 2 . In our initial experiments, we assessed the effects of neutral endopeptidase inhibition and C-fiber desensitization on capsaicin-induced release of PGE 2 . We also assessed the effects of the capsaicin vehicle. The results are summarized in Fig. 2 . In these experiments, basal levels of the PG were not different among the groups (P ϭ 0.063; Fig. 2 ). The DMSO vehicle did not cause appreciable release of PGE 2 . Capsaicin evoked release of PGE 2 from the isolated airway segments; the magnitude of the release was comparable to that caused by substance P. Desensitization of C fibers by prior exposure to capsaicin blocked the release of PGE 2 caused by subsequent exposure to capsaicin. Phosphoramidon did not enhance capsaicin-induced release of PGE 2 . Although inhibition of neutral endopeptidase did not affect the release of PGE 2 caused by capsaicin, we included phosphoramidon in the medium in subsequent experiments.
The results in Fig. 3 show the effects of cyclooxygenase inhibition, NK 1 -receptor antagonism, and epithelium removal on capsaicin-induced release of PGE 2 from airway segments; each of the interventions blocked release of PGE 2 . In these experiments, basal release of PGE 2 in meclofenamate-treated airways was significantly reduced relative to control segments (P ϭ 0.002).
DISCUSSION
In this study, we found that activation of the sensory nerve inhibitory system caused release of PGE 2 from isolated airway segments, a finding heretofore unreported. Activation of this system was confirmed by the results of experiments in which desensitization of C fibers with capsaicin abolished release of PGE 2 in response to activation of the inhibitory system. The response was dependent on activation of NK 1 receptors on the epithelium because blockade of these receptors blocked release of PGE 2 from the segments. The fact that denuding the epithelium abolished PGE 2 release in response to activation of the sensory nerve inhibitory system implicates the epithelium as the cellular source of PGE 2 . Although not measured directly in this study, substance P may be one neuropeptide mediator in this system for two reasons: 1) substance P caused release of PGE 2 from the airway segments and 2) the same inhibitors that blocked the effects of activation of the sensory nerve inhibitory system also blocked the substance P-induced release of PGE 2 . The results of the present study confirm our proposed mechanism (35): activation of the sensory nerve inhibitory system re- http://ajplung.physiology.org/ leases sensory neuropeptides that activate NK 1 receptors on the epithelium, causing the release of PGE 2 , the ultimate mediator of smooth muscle relaxation (Fig. 4) .
The experiments in this study were designed to mimic the experimental conditions in our laboratory's functional study (35) with respect to increased smooth muscle tone by incubating the airway segments with bethanechol. Under these conditions, substance P evoked the release of PGE 2 from the isolated airway segments. In our functional study (35) , epithelium removal, NK 1 -receptor antagonism, and inhibition of cyclooxygenase abolished or markedly inhibited relaxation responses in contracted airways in response to substance P. Thus we examined the effects of these interventions on release of PGE 2 caused by substance P. Corroborating the results of the study by Devillier and co-workers (6), we showed that substance P-induced release of PGE 2 was abolished in segments that had been denuded of epithelium. Our results extend those of this previous study and show that blocking NK 1 receptors and inhibition of cyclooxygenase also abolished substance P-induced release of the prostanoid. Although other tachykinin receptors may be involved in releasing PGE 2 , we are convinced that the release of PGE 2 by substance P was mediated by the activation of NK 1 receptors for several reasons. First, RP-67580 is highly specific for rat NK 1 receptors (38). Garret and co-workers (13) showed that this nonpeptide antagonist in concentrations up to 10 µM (the concentration of RP-67580 used in the present study) did not displace the binding of NKA or senktide to NK 2 or NK 3 receptors, respectively. Moreover, in a previous functional study (35) , the NK 2 -receptor antagonist SR-48968 did not affect substance P-induced relaxation responses. We conclude from our observations that substance P activates NK 1 receptors on the epithelium followed by activation of cyclooxygenase and release of PGE 2 .
We found nearly identical results when capsaicin was used to activate C fibers within the airway segments. Removal of the epithelium, NK 1 -receptor antagonism, and inhibition of cyclooxygenase each blocked release of PGE 2 evoked by capsaicin. The fact that capsaicininduced release of the prostanoid was inhibited by desensitization of C fibers confirmed that PGE 2 release was dependent on activation of the sensory nerve inhibitory system. The finding that phosphoramidon did not affect capsaicin-induced release of PGE 2 reflects the fact that the concentration of capsaicin used in this study produces a near-maximal response that cannot be potentiated by inhibition of neutral endopeptidase. These results are the first to show that endogenous neuropeptides released from C fibers cause the release of PGE 2 and that the mechanism is identical to that used by exogenous substance P.
Of the several prostanoids that have been shown to relax airway smooth muscle, we focused on PGE 2 in this study for several reasons: 1) PGE 2 is the predominant prostanoid released from normal and transformed rat tracheal epithelial cells in culture (7, 40) ; 2) Devillier and co-workers (6) found that substance P did not evoke release of prostacyclin, thromboxane, or PGF 2␣ ; and 3) PGE 2 relaxes airway segments in a concentration-dependent manner, whereas prostacyclin does not exhibit inhibitory effects in rat airways (unpublished data). Pertaining to this latter finding, ϳ10 nM PGE 2 produced a relaxation response that was comparable to that observed in a previous study (35) by our laboratory in response to 1 µM substance P or capsaicin. The calculated concentration of PGE 2 in the medium after the addition of the same concentration of substance P and capsaicin in the present study was ϳ0.7 nM. This difference could be accounted for by release of another inhibitory PG that was not measured in this study. Alternatively, the difference between the amount of PGE 2 released and an equieffective concentration of exogenous PGE 2 can be attributed to the close apposition of the C fibers, epithelium, and smooth muscle in the airway wall that leads to higher local concentrations than those measured in the medium (Fig. 4) .
Several studies have examined tachykinin-receptor distribution and C-fiber distribution in the airways of the rat. Using 125 I-Bolton-Hunter-labeled substance P, Sertl and co-workers (31) showed that receptors for substance P were localized predominantly to the epithelial cells of rat bronchi similar to those used in the present study. The results of our study suggest that these receptors were most likely NK 1 receptors because the NK 1 -selective antagonist RP-67580 blocked release of PGE 2 in response to substance P. Using immunohistochemistry, investigators (10, 20) have localized the NK 1 receptors predominantly to the luminal surface of the epithelial cells. Immunohistochemical techniques have been utilized to locate the distribution of substance P-containing nerves within the airways of the rat. Baluk and co-workers (1) showed that, of the single substance P-immunoreactive axons within the airway wall, 85% of these were in the epithelium. These axons passed between and beneath the epithelial cells in the airway (1) . In another study, McDonald and co-workers (25) found that the substance P-immunoreactive nerves were within 0.1 µm of the epithelial cells. Thus endogenous neuropeptides released from activated C fibers have to traverse only a short distance before encountering epithelial NK 1 receptors. Although the actions of the released neuropeptide would be expected to be short-lived because of abundant neutral endopeptidase within the epithelium (30) , the proximity of the nerves to the epithelial receptors ensures the activation of the NK 1 receptors and subsequent release of PG before degradation of the neuropeptide.
Given the location of the C fibers in relation to the epithelium, it is possible that in the process of denuding the epithelium, we removed the nerves. To address this issue, we tried to measure substance P release from epithelium-intact and -denuded airway segments. After repeated attempts, we were not able to measure substance P release from the segments. We attribute this result to the small size of the airway segments. This contention is supported by results of a study by Hua and Yaksh (17) . Using an isolated perfused rat trachea, they measured the release of substance P, NKA, and calcitonin gene-related peptide (CGRP) in response to capsaicin. They were able to measure release of substance P in only two of six experiments in response to 1 µM capsaicin. Their data also showed that capsaicin caused ϳ10-fold more CGRP release than NKA and substance P. Many investigators have used CGRP release as an index of sensory nerve activation in the airways. In the discussion of their paper, Hua and Yaksh (17) mention that removing the epithelium did not alter basal secretion or capsaicinevoked release of CGRP. Assuming that our process of removing the epithelium from bronchi is similar to removing it from the trachea, this result suggests that the sensory nerves are not removed in the process of denuding the airway segments. Thus, in the experiments in which denuding the epithelium abolished the capsaicin-induced release of PGE 2 , we conclude that this was due to removal of the cellular source of PG.
In a previous study (35) , our laboratory showed that NKA mimicked the effects of substance P in producing relaxation responses, and these responses were blocked by inhibition of cyclooxygenase. Although there have been no quantitative studies of the distribution of NKA-immunoreactive nerves in the rat airways, there is evidence that NKA and substance P are present in the same axons (16) . Moreover, as mentioned above, substance P, NKA, and CGRP are released from rat airways in response to capsaicin (17) . Thus either one or all of these peptides may have contributed to the release of PGE 2 caused by capsaicin in the present study. However, a role for CGRP is precluded on the basis of the results of a functional study (35) by our laboratory. In that study, blocking CGRP receptors inhibited CGRP-induced relaxation but did not affect relaxation evoked by activation of the sensory nerve inhibitory system. We cannot assign a principal role for either endogenous substance P or NKA in mediating release of PGE 2 because both of these neuropeptides bind to and activate NK 1 receptors nonselectively (29) . Thus endogenous substance P, NKA, or both contribute to the release of PGE 2 after the activation of the sensory nerve inhibitory system. Inhibitory PGs represent epithelium-derived relaxing factors that modulate contractions in the airways (2). In our study, we focused on one of these, PGE 2 . In addition to the direct relaxant effects of PGE 2 on airway smooth muscle, PGE 2 inhibits release of acetylcholine from parasympathetic nerve endings (32) . PGE 2 also has anti-inflammatory activity. It inhibits release of mediators from lung mast cells (28) and inhibits cellular responses in other inflammatory cells such as eosinophils (14) and macrophages (5) . Substance P and other tachykinins are generally considered proinflammatory and mediate neurogenic inflammation. These effects include bronchoconstriction (19) , airway hyperresponsiveness to other bronchoactive stimuli (39) , augmentation of release of acetylcholine from cholinergic nerve endings (37) , vasodilation (24) , and increased vascular permeability (1) . A hypothetical scheme of the role of these autacoids in modulating airway responses begins to emerge. Specifically, substance P promotes inflammatory responses in the airways, whereas PGE 2 exerts a dampening effect. Hence the opposing roles in modulating airway function may serve to protect the lungs from excessive neurogenic inflammatory activity.
Results of our study may have relevance to the development of human lung disease; several previous studies suggest that a sensory nerve inhibitory system exists in the human lung. Activation of C fibers by aerosolized capsaicin has been shown to cause bronchodilation in humans (21, 22) . Intravenous infusion of substance P has also been shown to cause bronchodilation in humans (9); however, this effect may have been a consequence of the vasodilator response caused by the tachykinin. When administered as an aerosol, substance P in concentrations up to 1 µmol/ml was devoid of bronchomotor effects in normal human volunteers (18) . In a previous study (35) , our laboratory also did not see any bronchomotor effects of substance P in animals unless we first induced bronchoconstriction. Results of a recent in vitro study (4) showed that substance P caused a biphasic response in isolated human airways, transient relaxation followed by contraction. In this same study, a selective NK 1 -receptor agonist, [Sar 9 ,Met(O 2 ) 11 ]substance P, evoked relaxation of isolated human bronchi (4) . Capsaicin has been shown to cause no effect (26) , contraction only (15) , and contraction and/or relaxation (4) in isolated human airways. In a recent study (8) , investigators showed that very high concentrations of capsaicin caused relaxation responses in human bronchi but that these occurred independently of the release of endogenous tachykinins. Thus whether this system exists in human airways cannot be stated with certainty.
In support of the notion that a sensory nerve inhibitory system does exist in human airways, results of studies from other investigators showed that the neural and cellular components exist for such a system and that the inhibitory pathway is similar to that which we showed in the rat (Fig. 4) . Substance P-immunoreactive nerves exist in the epithelial basement membrane of human airways and have branches extending into the epithelium (27) ; NK 1 receptors are localized to the epithelium of the airways predominantly on the luminal side (10); and, as mentioned above, NK 1 -receptor activation relaxes isolated human bronchi (4). The http://ajplung.physiology.org/ presence of a similar system in human airways suggests that studies in the rat are relevant to human airway function.
Epithelial damage is a prominent histological feature of asthmatic airways. Thus our results suggest that such damage to the epithelium would remove the dampening effects of PGE 2 in the airways, resulting in exaggerated effects of C-fiber activation. This may contribute to the development of airway diseases such as asthma. In support of this contention, inhaled substance P causes bronchoconstriction in asthmatic subjects (3, 12) . Moreover, we have shown that acute ablation of C-fiber function in isolated airways enhanced electrical field stimulation-induced contractions in the airway segments and that replacement of substance P inhibited these contractions (34) .
In conclusion, our results show that PGE 2 released from the epithelium likely represents the ultimate mediator responsible for relaxation of smooth muscle in response to activation of the sensory nerve inhibitory system.
